Diabetes Care 48(7):11011111 Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
The timeline depends on how you lost weight, whether your medication dose is still changing, whether you underwent bariatric surgery and whether your health and nutrition have stabilized
Alcoholparticularly beer, wine, and spirits on an empty stomachcan worsen gastric distress and trigger or amplify nausea
B12 levels are rarely monitored once they are within acceptable range, and there is no concern if levels a higher than the deemed acceptable range